195 related articles for article (PubMed ID: 23624618)
1. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
Yang M; Gao H; Chen P; Jia J; Wu S
Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
[TBL] [Abstract][Full Text] [Related]
2. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
3. Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer.
Hu J; Wang S; Zhao Y; Guo Q; Zhang D; Chen J; Li J; Fei Q; Sun Y
Oncol Rep; 2014 Dec; 32(6):2648-56. PubMed ID: 25270246
[TBL] [Abstract][Full Text] [Related]
4. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
5. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells.
Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL
Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097
[TBL] [Abstract][Full Text] [Related]
6. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
[TBL] [Abstract][Full Text] [Related]
7. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
[TBL] [Abstract][Full Text] [Related]
8. Lentivirus-mediated knockdown of NOB1 suppresses the proliferation of colon cancer cells.
Liu Y; Huang H; Yuan B; Zhuang LY; Luo TP; Zhang Q
Z Gastroenterol; 2014 May; 52(5):429-35. PubMed ID: 24824907
[TBL] [Abstract][Full Text] [Related]
9. [Growth inhibition and multidrug resistance-reversing effect of tanshinone I A on human breast cancer cell with estrogen receptor negative].
Jing J; Zheng H; Wang J; Lin P; Zhang J; Xiong ZJ; Wu YY; Ren JJ; Yang HL; Wang XJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):391-5. PubMed ID: 17593814
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.
Lian WJ; Liu G; Liu YJ; Zhao ZW; Yi T; Zhou HY
Oncol Rep; 2013 Jul; 30(1):193-200. PubMed ID: 23674072
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated knockdown of CEP55 suppresses cell proliferation of breast cancer cells.
Wang Y; Jin T; Dai X; Xu J
Biosci Trends; 2016 Feb; 10(1):67-73. PubMed ID: 26902787
[TBL] [Abstract][Full Text] [Related]
15. Eps8 regulates cellular proliferation and migration of breast cancer.
Chen C; Liang Z; Huang W; Li X; Zhou F; Hu X; Han M; Ding X; Xiang S
Int J Oncol; 2015 Jan; 46(1):205-14. PubMed ID: 25333707
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.
Yang H; He X; Zheng Y; Feng W; Xia X; Yu X; Lin Z
Chem Biol Drug Des; 2014 Nov; 84(5):578-84. PubMed ID: 24775638
[TBL] [Abstract][Full Text] [Related]
17. The role of IFITM3 in the growth and migration of human glioma cells.
Zhao B; Wang H; Zong G; Li P
BMC Neurol; 2013 Dec; 13():210. PubMed ID: 24370119
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
19. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
20. Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation.
Choong LY; Lim SK; Chen Y; Loh MC; Toy W; Wong CY; Salto-Tellez M; Shah N; Lim YP
Genes Chromosomes Cancer; 2011 Oct; 50(10):837-47. PubMed ID: 21769958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]